mgus and risk of chronic kidney disease: results of the population-based istopmm study
Published 1 year ago • 792 plays • Length 5:55Download video MP4
Download video MP3
Similar videos
-
8:14
autoimmune diseases are not associated with mgus: results of the population-based istopmm
-
2:59
what is mgus?
-
5:42
hypercalcemia in individuals with mgus: results from the istopmm study
-
3:13
is there a link between mgus and kidney damage in myeloma patients?
-
6:00
istopmm - one year update
-
11:22
monoclonal gammopathy of undetermined significance and covid-19: results from istopmm
-
4:13
estimating selection bias in previous mgus research-the importance of screening results from istopmm
-
4:55
what is monoclonal gammopathy of renal significance?
-
3:16
are there medical issues linked to mgus other than developing multiple myeloma?
-
3:22
are mgus patients at higher risk of getting severely ill from covid-19?
-
1:56
do mgus patients have a higher risk of fracture than people without mgus? why?
-
1:47
risk stratification of mgus
-
3:47
what is mgus? is it cancer? how many people have mgus, and how long can i have it?
-
3:04
identifying high-risk patients with smm & mgus to prevent progression to active myeloma
-
4:37
multiple myeloma precursor conditions | high impact topic (hit)
-
2:02
mgus and autoimmune disease
-
2:33
why do some myeloma patients experience chronic kidney disease?
-
28:51
diagnosis and risk stratification of plasma cell disorders (pt 1 of 5 - imf ash satellite)
-
4:51
causes & management of renal impairment in patients with multiple myeloma